The bill aims to enhance the availability of nonopioid drugs for pain management by mandating that health plans and managed care organizations provide coverage for at least one nonopioid drug without requiring prior authorization or step therapy protocols, effective January 1, 2027. A new section is added to chapter 48.43 RCW, which defines "nonopioid drug" as a product approved by the FDA that produces analgesia without acting on opioid receptors. Additionally, the bill amends RCW 41.05.017 to include this new requirement and ensures that managed care organizations under chapter 74.09 RCW comply with the same coverage stipulations.

Furthermore, the bill requires the Department of Health to develop and publish an educational pamphlet by January 1, 2027, detailing nonopioid alternatives for pain treatment, including their advantages and disadvantages. The bill also amends RCW 48.43.400 to incorporate references to the new section regarding nonopioid drugs, ensuring that the definitions and provisions related to clinical practice guidelines and prescription drug utilization management are aligned with the new requirements.

Statutes affected:
Original bill: 48.43.400
Substitute bill: 48.43.400